Nº COLEGIADO
Maria Martina Lingua
| CENTROS | |
| IDIOMAS |
|
Solicita ahora mismo tu cita online
o llamando al teléfono +34 971 280 000
Licenciada en Medicina y Cirugía por la Universidad NAcional de Córdoba, Argentina
Especialista en Nefrología vía MIR en Hospital Clínic Barcelona
Beca de investigación, LENIT Instituto, Barcelona.
Beca departamento de Patología de la Universidad Johns Hopkins, Baltimore.
Excelencia en Investigación básica: "Analysis of kidney double negative T Cells in the steady state and acute Kidney injury". Departamento de Patología. Universidad Johns Hopkins, Baltimore.
Premio Joven Investigador Sociedad Catalana de Trasplantes. "Inhibition of JAK3, PKC, and m-TOR in Humoral Rejection"
Nefrología Clínica
Litiasis
Glomerulonefritis
Enfermedad renal crónica
Double-Negative αβ T Cells Are Early Responders to AKI and Are Found in Human Kidney. J Am Soc Nephrol. 2015 - Martina MN, Noel S, Saxena A, Bandapalle S,, Rabb H, Hamad AR.
T Lymphocyte-Specific Activation of Nrf2 Protects from AKI. J Am Soc Nephrol. 2015 - Noel S, Martina MN, Bandapalle S, Racusen LC, Potteti HR, Hamad AR, Reddy SP, Rabb H.
Double negative (DN) αβ T cells: misperception and overdue recognition. Immunol Cell Biol. 2015 - Martina MN, Noel S, Saxena A, Rabb H, Hamad AR.
T lymphocytes and acute kidney injury: update. Nephron Clin Pract. 2014 - Martina MN, Noel S, Bandapalle S, Hamad AR, Rabb H.
Co-PI for “The Detecting Bowel Cancer in Chronic Kidney disease
(DETECT)”. Collaborative program of research in Australia, New Zealand and Europe
which evaluates the test performance characteristics of iFOBT and the costeffectiveness of colorectal cancer screening in CKD (2012-2013)
“INHIBITION OF JAK3, PKC, OF PROTEASES AND mTOR IN HUMORAL
REJECTION” IP: F. Diekmann. Hospital Clinic. Barcelona (2012)
“Effect of protease inhibition on antibody-mediated pathology in twoexperimental
models - lupus erythematosus and chronic humoral rejection of renal allograft”. IP: JM
Campistol. Barcelona (2011)
Sub-Research Coordinator. Clinic Assay: “Study of the Safety, PK, and Clinical
Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing
Deceased Donor Kidney Transplantation ”Code: QRK 006” IP: JM Campistol. Hospital
Clinic. Barcelona (2011)
Collaborator Clinic Assay: “Planned Transition to Sirolimus-based Therapy versus
Continued Tacrolimus-based Therapy in Renal Allograft Recipients. Code: 0468E8-
4500” IP: JM Campistol. Barcelona (2010)
